176 related articles for article (PubMed ID: 23533681)
1. Fv1 restriction and retrovirus vaccine immunity in Apobec3-deficient 129P2 mice.
Halemano K; Barrett BS; Li SX; Harper MS; Smith DS; Heilman KJ; Santiago ML
PLoS One; 2013; 8(3):e60500. PubMed ID: 23533681
[TBL] [Abstract][Full Text] [Related]
2. Persistent Friend virus replication and disease in Apobec3-deficient mice expressing functional B-cell-activating factor receptor.
Santiago ML; Smith DS; Barrett BS; Montano M; Benitez RL; Pelanda R; Hasenkrug KJ; Greene WC
J Virol; 2011 Jan; 85(1):189-99. PubMed ID: 20980520
[TBL] [Abstract][Full Text] [Related]
3. Innate retroviral restriction by Apobec3 promotes antibody affinity maturation in vivo.
Santiago ML; Benitez RL; Montano M; Hasenkrug KJ; Greene WC
J Immunol; 2010 Jul; 185(2):1114-23. PubMed ID: 20566830
[TBL] [Abstract][Full Text] [Related]
4. Persistence of viremia and production of neutralizing antibodies differentially regulated by polymorphic APOBEC3 and BAFF-R loci in friend virus-infected mice.
Tsuji-Kawahara S; Chikaishi T; Takeda E; Kato M; Kinoshita S; Kajiwara E; Takamura S; Miyazawa M
J Virol; 2010 Jun; 84(12):6082-95. PubMed ID: 20375169
[TBL] [Abstract][Full Text] [Related]
5. Apobec3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection.
Santiago ML; Montano M; Benitez R; Messer RJ; Yonemoto W; Chesebro B; Hasenkrug KJ; Greene WC
Science; 2008 Sep; 321(5894):1343-6. PubMed ID: 18772436
[TBL] [Abstract][Full Text] [Related]
6. Noninfectious retrovirus particles drive the APOBEC3/Rfv3 dependent neutralizing antibody response.
Smith DS; Guo K; Barrett BS; Heilman KJ; Evans LH; Hasenkrug KJ; Greene WC; Santiago ML
PLoS Pathog; 2011 Oct; 7(10):e1002284. PubMed ID: 21998583
[TBL] [Abstract][Full Text] [Related]
7. Type I interferon signaling is required for the APOBEC3/Rfv3-dependent neutralizing antibody response but not innate retrovirus restriction.
Barrett BS; Harper MS; Jones ST; Guo K; Heilman KJ; Kedl RM; Hasenkrug KJ; Santiago ML
Retrovirology; 2017 Apr; 14(1):25. PubMed ID: 28415995
[TBL] [Abstract][Full Text] [Related]
8. Immunoglobulin somatic hypermutation by APOBEC3/Rfv3 during retroviral infection.
Halemano K; Guo K; Heilman KJ; Barrett BS; Smith DS; Hasenkrug KJ; Santiago ML
Proc Natl Acad Sci U S A; 2014 May; 111(21):7759-64. PubMed ID: 24821801
[TBL] [Abstract][Full Text] [Related]
9. IFN-α treatment inhibits acute Friend retrovirus replication primarily through the antiviral effector molecule Apobec3.
Harper MS; Barrett BS; Smith DS; Li SX; Gibbert K; Dittmer U; Hasenkrug KJ; Santiago ML
J Immunol; 2013 Feb; 190(4):1583-90. PubMed ID: 23315078
[TBL] [Abstract][Full Text] [Related]
10. Mouse APOBEC3 restricts friend leukemia virus infection and pathogenesis in vivo.
Takeda E; Tsuji-Kawahara S; Sakamoto M; Langlois MA; Neuberger MS; Rada C; Miyazawa M
J Virol; 2008 Nov; 82(22):10998-1008. PubMed ID: 18786991
[TBL] [Abstract][Full Text] [Related]
11. Antiretroviral restriction factors in mice.
Nair S; Rein A
Virus Res; 2014 Nov; 193():130-4. PubMed ID: 25018022
[TBL] [Abstract][Full Text] [Related]
12. Deaminase-Dead Mouse APOBEC3 Is an
Stavrou S; Zhao W; Blouch K; Ross SR
J Virol; 2018 Jun; 92(11):. PubMed ID: 29593034
[TBL] [Abstract][Full Text] [Related]
13. Expression levels of Fv1: effects on retroviral restriction specificities.
Li W; Yap MW; Voss V; Stoye JP
Retrovirology; 2016 Jun; 13(1):42. PubMed ID: 27342974
[TBL] [Abstract][Full Text] [Related]
14. Requirement for Fc effector mechanisms in the APOBEC3/Rfv3-dependent neutralizing antibody response.
Halemano K; Barrett BS; Heilman KJ; Morrison TE; Santiago ML
J Virol; 2015 Apr; 89(7):4011-4. PubMed ID: 25589647
[TBL] [Abstract][Full Text] [Related]
15. Reassessment of murine APOBEC1 as a retrovirus restriction factor in vivo.
Barrett BS; Guo K; Harper MS; Li SX; Heilman KJ; Davidson NO; Santiago ML
Virology; 2014 Nov; 468-470():601-608. PubMed ID: 25303118
[TBL] [Abstract][Full Text] [Related]
16. Complex determinants within the Moloney murine leukemia virus capsid modulate susceptibility of the virus to Fv1 and Ref1-mediated restriction.
Ulm JW; Perron M; Sodroski J; C Mulligan R
Virology; 2007 Jul; 363(2):245-55. PubMed ID: 17343889
[TBL] [Abstract][Full Text] [Related]
17. Evolution of the retroviral restriction gene Fv1: inhibition of non-MLV retroviruses.
Yap MW; Colbeck E; Ellis SA; Stoye JP
PLoS Pathog; 2014 Mar; 10(3):e1003968. PubMed ID: 24603659
[TBL] [Abstract][Full Text] [Related]
18. Tetherin/BST-2 promotes dendritic cell activation and function during acute retrovirus infection.
Li SX; Barrett BS; Guo K; Kassiotis G; Hasenkrug KJ; Dittmer U; Gibbert K; Santiago ML
Sci Rep; 2016 Feb; 6():20425. PubMed ID: 26846717
[TBL] [Abstract][Full Text] [Related]
19. Murine Leukemia Virus P50 Protein Counteracts APOBEC3 by Blocking Its Packaging.
Zhao W; Akkawi C; Mougel M; Ross SR
J Virol; 2020 Aug; 94(18):. PubMed ID: 32641479
[TBL] [Abstract][Full Text] [Related]
20. Ribonuclease L is not critical for innate restriction and adaptive immunity against Friend retrovirus infection.
Li SX; Barrett BS; Harper MS; Heilman KJ; Halemano K; Steele AK; Guo K; Silverman RH; Santiago ML
Virology; 2013 Aug; 443(1):134-42. PubMed ID: 23725696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
